Key facts
- Peachy (Services (B2C Non-Financial))’s last known valuation is $125.0M (Jun 2023).
- It has raised $29.6M; the latest was PE Growth/Expansion in Apr 2026.
- Notable investors include FJ Labs, Evolution VC Partners, Great Oaks Venture Capital, Base10 Partners, The MBA Fund — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Peachy (Services (B2C Non-Financial))
- ·The full record, as it builds
Funding rounds
No funding rounds for Peachy (Services (B2C Non-Financial)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Peachy (Services (B2C Non-Financial))
Operator of a chain of botox studios intended to offer wrinkle treatments, prescription retinoids, and skincare products. The company's studios deliver skin care through science and tailored through a preventative blend of Botox, prescription retinoids, and daily-use sunscreen, enabling customers to get positive change in skin across all operational segments.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 165
- Website
- peachystudio.com/
- Ownership
- Privately Held (backing)
Peachy (Services (B2C Non-Financial)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Peachy (Services (B2C Non-Financial)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Peachy (Services (B2C Non-Financial)) in its N-PORT filings yet. We sweep new filings monthly.